Mohammad Shahrokh Esfahani
Stanford University
H-index: 25
North America-United States
Top articles of Mohammad Shahrokh Esfahani
MP71-19 ULTRASENSITIVE URINARY LIQUID BIOPSY ANALYSIS FOR BCG RESPONSE ASSESSMENT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
The Journal of Urology
2024/5
Cell-free RNA analysis for non-invasive cancer detection and characterization
Cancer Research
2024/3/22
CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Associated Cytopenias
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
2024/2/1
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
Cancer Cell
2023/1/9
Mohammad Shahrokh Esfahani
H-Index: 18
James Hamilton
H-Index: 7
Mark Hamilton
H-Index: 6
Takeshi Sugio
H-Index: 6
Sara Beygi
H-Index: 10
Maximilian Diehn
H-Index: 51
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Nature
2024/1/25
Mohammad Shahrokh Esfahani
H-Index: 18
Shengqin Su
H-Index: 2
Feng Tian
H-Index: 2
Thomas Tousseyn
H-Index: 37
Richard Hoppe
H-Index: 51
Davide Rossi
H-Index: 27
Maximilian Diehn
H-Index: 51
Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults
Blood
2023/11/28
Mohammad Shahrokh Esfahani
H-Index: 18
Takeshi Sugio
H-Index: 6
Mark P Hamilton
H-Index: 16
Maximilian Diehn
H-Index: 51
An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring
Blood
2023/11/28
Takeshi Sugio
H-Index: 6
Monica Nesselbush
H-Index: 5
Mohammad Shahrokh Esfahani
H-Index: 18
Mark P Hamilton
H-Index: 16
Maximilian Diehn
H-Index: 51
Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma
Blood
2023/11/28
Mohammad Shahrokh Esfahani
H-Index: 18
Florian Scherer
H-Index: 13
Joanne Soo
H-Index: 5
Takeshi Sugio
H-Index: 6
Maximilian Diehn
H-Index: 51
Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification
Blood
2023/11/28
Mohammad Shahrokh Esfahani
H-Index: 18
Mark P Hamilton
H-Index: 16
Takeshi Sugio
H-Index: 6
Maximilian Diehn
H-Index: 51
Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods
Blood
2023/11/2
Distinct Hodgkin lymphoma subtypes identified by noninvasive genomic profiling
17th International Conference on Malignant Lymphoma
2023/6/13
Distinct molecular determinants of treatment‐failure in elderly Hodgkin lymphoma identified by cell‐free DNA profiling: A LYSA Study
Hematological Oncology
2023/6
COMPARATIVE ACCURACY OF ALTERNATIVE EARLY MEASURES OF RESIDUAL DISEASE AFTER CAR19 THERAPY OF RELAPSED/REFRACTORY LBCL
Hematological Oncology
2023/6
RePhyNER: Overcoming limitations of access to matched germline for serial liquid biopsy applications
Cancer Research
2023/4/4
Improved cfDNA methylation profiling through correction of misrepaired jagged-ends
Cancer Research
2023/4/4
Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas
Journal of Clinical Oncology
2023/3/20
Methods to Assess Clinical Outcome Based Upon Updated Probabilities and Treatments Thereof
2022/12/8
Accurate Detection of Clinically Actionable Copy Number Variants in Diverse Hematological Neoplasms By Routine Targeted Sequencing: A Comparative Performance Study
Blood
2022/11/15
Mohammad Shahrokh Esfahani
H-Index: 18
Distinct molecular subtypes of classic Hodgkin lymphoma identified by comprehensive noninvasive profiling
Blood
2022/11/15
Mohammad Shahrokh Esfahani
H-Index: 18
Michael Y Li
H-Index: 31
Davide Rossi
H-Index: 27
Ryan C Lynch
H-Index: 15
Maximilian Diehn
H-Index: 51
Higher rates of severe infection and persistent cytopenias in long-term CAR19 responders than after autologous HCT: a single institution study of 139 subjects
Blood
2022/11/15
Mark P Hamilton
H-Index: 16
Mohammad Shahrokh Esfahani
H-Index: 18
Zinaida Good
H-Index: 9
Ying Lu
H-Index: 5
Wen-Kai Weng
H-Index: 14
Saurabh Dahiya
H-Index: 12
Maximilian Diehn
H-Index: 51
Co-Authors
